Evidence map›Paper›PMID 31627732›Full record

ArticleActa neuropathologica communications2019

Correction to: Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis.

Praveena Manogaran, Marijana Samardzija, Anaïs Nura Schad, Carla Andrea Wicki, Christine Walker-Egger, Markus Rudin, Christian Grimm, Sven Schippling

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Acta neuropathologica communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Praveena ManogaranDepartment of Information Technology and Electrical Engineering, Swiss Federal Institute of Technology, Zurich, Switzerland. pmanogar@student.ethz.ch.
Marijana SamardzijaDepartment of Ophthalmology, Lab for Retinal Cell Biology, University of Zurich, Zurich, Switzerland.
Anaïs Nura SchadDepartment of Biology, University of Zurich, Zurich, Switzerland.
Carla Andrea WickiNeuroimmunology and Multiple Sclerosis Research, Clinic for Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Christine Walker-EggerNeuroimmunology and Multiple Sclerosis Research, Clinic for Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Markus RudinDepartment of Information Technology and Electrical Engineering, Swiss Federal Institute of Technology, Zurich, Switzerland.
Christian GrimmDepartment of Ophthalmology, Lab for Retinal Cell Biology, University of Zurich, Zurich, Switzerland.
Sven SchipplingNeuroimmunology and Multiple Sclerosis Research, Clinic for Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
University of Zurich · CHÉcole Polytechnique Fédérale de Lausanne · CHUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication of this article [1], Fig. 10 contained two panels "C" as panel "F" was accidentally omitted. The incorrect (Fig. 1) and correct (Fig. 2) versions are published in this correction article.

Identifiers

PMID31627732
PMCPMC6798424
OpenAlexW2980409118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.